Analysts See $-0.23 EPS for BioDelivery Sciences International, Inc. (BDSI); Texas Instruments (TXN) Sellers Increased By 5.68% Their Shorts

February 15, 2018 - By Marguerite Chambers

Texas Instruments (NASDAQ:TXN) had an increase of 5.68% in short interest. TXN’s SI was 11.64M shares in February as released by FINRA. Its up 5.68% from 11.01 million shares previously. With 3.74M avg volume, 3 days are for Texas Instruments (NASDAQ:TXN)’s short sellers to cover TXN’s short positions. The stock increased 1.68% or $1.7 during the last trading session, reaching $102.68. About 7.41 million shares traded or 25.44% up from the average. Texas Instruments Incorporated (NASDAQ:TXN) has risen 40.31% since February 15, 2017 and is uptrending. It has outperformed by 23.61% the S&P500.

Analysts expect BioDelivery Sciences International, Inc. (NASDAQ:BDSI) to report $-0.23 EPS on March, 16.They anticipate $0.06 EPS change or 20.69% from last quarter’s $-0.29 EPS. After having $-0.21 EPS previously, BioDelivery Sciences International, Inc.’s analysts see 9.52% EPS growth. The stock decreased 9.38% or $0.225 during the last trading session, reaching $2.175. About 476,802 shares traded. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has risen 24.37% since February 15, 2017 and is uptrending. It has outperformed by 7.67% the S&P500.

Since September 14, 2017, it had 0 insider buys, and 2 selling transactions for $2.51 million activity. Sirgo Mark A had sold 201,373 shares worth $572,601.

Investors sentiment increased to 1.67 in 2017 Q3. Its up 0.67, from 1 in 2017Q2. It increased, as 8 investors sold BioDelivery Sciences International, Inc. shares while 7 reduced holdings. 6 funds opened positions while 19 raised stakes. 20.34 million shares or 6.83% more from 19.04 million shares in 2017Q2 were reported. Valley Natl Advisers invested in 0.04% or 37,715 shares. Broadfin Cap Ltd Limited Liability Company has invested 1.92% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Price T Rowe Assoc Md holds 0% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) or 31,500 shares. Jpmorgan Chase And reported 0% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Sterling Invest invested in 0.2% or 50,000 shares. Virtu Fincl Lc holds 0% or 26,601 shares in its portfolio. Sigma Planning Corporation, Michigan-based fund reported 14,472 shares. Citadel Advsrs Limited Liability Com reported 75,164 shares stake. Morgan Stanley accumulated 133,381 shares or 0% of the stock. Fny Managed Accounts Ltd Limited Liability Company reported 3,200 shares or 0.01% of all its holdings. Gsa Prns Ltd Liability Partnership invested in 0.08% or 408,667 shares. Ameriprise Inc holds 1.43M shares. Citigroup holds 0% or 1,000 shares. Us Bank & Trust De stated it has 200 shares. Archford Cap Strategies Ltd Co has invested 0.04% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI).

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company has market cap of $121.55 million. The firm provides its products based on its patented BioErodible MucoAdhesive drug delivery technology, which consists of a small, erodible polymer film for application to the buccal mucosa. It has a 21.53 P/E ratio. It offers ONSOLIS, a fentanyl buccal soluble film to treat breakthrough pain in opioid patients with cancer; BUNAVAIL, a buprenorphine and naloxone buccal film for the treatment of opioid dependence; and BELBUCA, a buprenorphine buccal film for the treatment of chronic pain.

Among 7 analysts covering BioDelivery Sciences International (NASDAQ:BDSI), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioDelivery Sciences International had 32 analyst reports since August 16, 2015 according to SRatingsIntel. The stock of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has “Buy” rating given on Monday, November 13 by Roth Capital. The firm has “Buy” rating by FBR Capital given on Wednesday, June 21. Piper Jaffray maintained the stock with “Buy” rating in Wednesday, August 9 report. FBR Capital maintained the shares of BDSI in report on Tuesday, November 10 with “Mkt Perform” rating. The rating was maintained by H.C. Wainwright on Friday, October 13 with “Buy”. Janney Capital initiated BioDelivery Sciences International, Inc. (NASDAQ:BDSI) on Tuesday, October 27 with “Neutral” rating. On Thursday, May 12 the stock rating was maintained by Piper Jaffray with “Overweight”. Cantor Fitzgerald upgraded the shares of BDSI in report on Wednesday, May 17 to “Overweight” rating. H.C. Wainwright maintained the shares of BDSI in report on Friday, June 9 with “Buy” rating. The stock of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) earned “Buy” rating by H.C. Wainwright on Tuesday, February 6.

Among 40 analysts covering Texas Instruments (NASDAQ:TXN), 19 have Buy rating, 2 Sell and 19 Hold. Therefore 48% are positive. Texas Instruments had 111 analyst reports since July 24, 2015 according to SRatingsIntel. On Tuesday, July 26 the stock rating was upgraded by Bank of America to “Buy”. The firm has “Buy” rating by Citigroup given on Monday, September 25. The firm has “Neutral” rating by Mizuho given on Wednesday, January 25. The company was upgraded on Wednesday, February 7 by Credit Suisse. Cowen & Co maintained the stock with “Market Perform” rating in Thursday, October 27 report. UBS maintained it with “Buy” rating and $62.0 target in Thursday, October 22 report. On Monday, August 22 the stock rating was maintained by RBC Capital Markets with “Outperform”. As per Thursday, August 31, the company rating was maintained by BMO Capital Markets. The company was maintained on Thursday, April 28 by RBC Capital Markets. Mizuho maintained it with “Neutral” rating and $68 target in Thursday, October 27 report.

Texas Instruments Incorporated designs, makes, and sells semiconductors to electronics designers and manufacturers worldwide. The company has market cap of $100.95 billion. The firm operates through two divisions, Analog and Embedded Processing. It has a 28.47 P/E ratio. The Analog segment offers high volume analog and logic products for automotive safety devices, touch screen controllers, low voltage motor drivers, and integrated motor controllers; and power products to manage power requirements using battery management solutions, portable power components, power supply controls, and point-of-load products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: